KYTHERA BIOPHARMACEUTICALS I's ticker is KYTH and the CUSIP is 501570105. A total of 103 filers reported holding KYTHERA BIOPHARMACEUTICALS I in Q1 2014. The put-call ratio across all filers is 0.85 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $5,150,601,000 | +2975.2% | 68,693 | +2988.7% | 0.01% | – |
| Q2 2015 | $167,489,000 | +700.9% | 2,224 | +433.3% | 0.00% | – |
| Q1 2015 | $20,913,000 | -38.1% | 417 | -59.6% | 0.00% | – |
| Q3 2014 | $33,776,000 | +1401.2% | 1,031 | +1394.2% | 0.00% | – |
| Q1 2014 | $2,250,000 | -69.0% | 69 | -64.6% | 0.00% | – |
| Q4 2013 | $7,264,000 | – | 195 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 34,925 | $1,596,000 | 1.83% |
| Redmile Group, LLC | 228,218 | $10,430,000 | 1.57% |
| Palo Alto Investors LP | 319,113 | $14,548,000 | 1.52% |
| Aureus Asset Management, LLC | 92,350 | $4,210,000 | 1.44% |
| PFM Health Sciences, LP | 767,892 | $35,007,000 | 0.84% |
| EAM Investors, LLC | 60,219 | $2,752,000 | 0.55% |
| INVESTOR AB | 80,000 | $3,540,000 | 0.41% |
| Partner Investment Management, L.P. | 23,595 | $1,076,000 | 0.29% |
| Polar Capital LLP | 230,000 | $10,511,000 | 0.28% |
| Old West Investment Management, LLC | 11,130 | $507,000 | 0.24% |